FDA Inspection 989445 — GPT Pharmaceuticals Private Ltd

GPT Pharmaceuticals Private Ltd — FEI 3008311641

The FDA completed an inspection of GPT Pharmaceuticals Private Ltd on July 29, 2016 in Hyderabad. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 4 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 29, 2016
Fiscal Year
2016
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Hyderabad (India)

Citations

IDCFRDescription
135821 CFR 211.100(b)SOPs not followed / documented
200821 CFR 211.186(a)Written procedures followed
202721 CFR 211.192Investigations of discrepancies, failures
357121 CFR 211.100(a)Changes to Procedures Not Reviewed, Approved